Dividend Overview
Dividend Yield
—
Dividend / Share
—
Amedisys Inc
Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and high-acuity care services. Amedisys is focused on delivering the care that is best for our patients, whether that is inpatient hospital, palliative, and skilled nursing facility (“SNF”) care in their homes; home-based recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. Nearly 3,000 hospitals and more than 110,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 19,000 employees in 521 care centers in 37 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of nearly 470,000 patients in need every year, performing more than 10.6 million visits annually.
Net income compounded at -15.6% annually over 6 years.
Current Price
$100.99
+0.01%GoodMoat Value
$205.64
103.6% undervaluedDividend Yield
—
Dividend / Share
—
Market Cap
$3.31B
P/E Ratio
38.71
Forward P/E
—
EPS
$1.31
PEG Ratio
-2.74
Book Value
$34.57
Dividend Yield
—
Profit Margin
3.56%
ROE
7.55%
Amedisys Inc (AMED) dividend analysis including yield, payout history, and sustainability metrics.
P/E ratio: 38.71. Profit margin: 3.56%. Free cash flow: $215.12M. This page shows Amedisys Inc's dividend overview, key metrics, historical payout data, and dividend safety assessment to help income-focused investors evaluate the sustainability of dividend payments.
GoodMoat's dividend analyzer evaluates payout ratios, earnings coverage, and free cash flow coverage to determine how well supported Amedisys Inc's dividend payments are. Use this analysis alongside the company's financial statements and quality score to make informed income-investing decisions.